Who owns CAN FITE BIOFARMA LTD?
- Ticker: CANF
- CUSIP Number: 13471n300
Tip: Access positions for across all investors
Analyze quarterly positions in Can Fite Biofarma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Can Fite Biofarma stock
Who bought or sold CAN FITE BIOFARMA LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 383k | $850k | 100% | Mar 2024 |
|
| Morgan Stanley | 56k | $124k | 69% | Mar 2024 |
|
| Rhumbline Advisers | 19k | $41k | 0% | Mar 2024 |
|
| Citadel Advisors | 14k | $32k | 100% | Mar 2024 |
|
| Fifth Third Bancorp | 3.0k | $6.7k | 0% | Mar 2024 |
|
| UBS Group | 2.2k | $4.8k | 100% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 600.00 | $1.2k | 0% | Dec 2023 |
|
| Citigroup | 553.00 | $1.2k | 0% | Mar 2024 |
|
Who sold out of Can Fite Biofarma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Schechter Investment Advisors | Dec 2023 | 20k | $44k |
| Susquehanna International | Sep 2023 | 12k | $32k |